NAE1 and cancer: Our results showing that Pevonedistat activity correlates more closely with TA than NAE1 and its downstream mediators suggest that a measure of TA, such as the multi-omic TA Score derived in this study, may be a valuable biomarker for guiding Pevonedistat treatment in future trials of specific cancer types.